MHRA’s Lee To Give UK Medtech Industry Greater Diagnostics Focus
The UK ABHI has created a new role for a director of diagnostics regulation, which MHRA IVD’s policy adviser Steve Lee will fill later this month.
You may also be interested in...
NHS England’s Long Term Plan puts much emphasis on better use of diagnostic tools in health-care delivery. The UK medtech industry is now pressing for a strategy to ensure that these technologies are factored into all patient pathways. It says the data derived will be used to improve patient outcomes and system efficiency.
During the week of the ostensibly pivotal EU Summit on Brexit, the UK government has made the EU27 wait for its white paper on proposed post-EU trading arrangements. The UK medtech industry, in turn, is kept waiting on its EU future. But far from remaining idle, manufacturers are focusing on innovation adoption and working with the NHS, where there is a new sense of purpose, and maybe a light at the end of the tunnel.
BVMed says the EU and the UK should set up a system of mutual recognition of medical device regulation to kick in when the UK’s EU exit transition period ends on 31 December.